How Much Upside Is Left in JNJ Stock?
While the market fixates on the STELARA patent cliff, the rest of the story is being missed. That…
Johnson & Johnson Is Becoming A Narrower Company Than You Bought
Management’s plain health care label has slipped out of the lead, and the business now on a separation…
Abbott Just Showed Its Growth Engine Has More Than One Cylinder
The healthcare giant’s stock jump was about more than an earnings beat, offering proof of a growth story…